Peptides in 2026, What the FDA Review Means Olympia Pharmaceuticals The FDA just changed the rules on peptides effective April 15, 2026. BPC 157, GHK Cu, MOTS C, and TB 500 have been removed from the Category 2 restricted compounding list. Here is what US Smoking Cessation: Your Gateway to the $24.8B NRT Market BPC 157 has a decades long safety record with zero deaths or hospitalizations. Yet, it's unapproved because the FDA process is too expensive and the business model doesn't allow for profit. Approved drugs with boomrx #peptides #fda #compoundingpharmacy #clinicalmedicine #patientaccess BoomRX